By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ago By Jon Springer - 2 hours 35 min ago By Ad Age ...

We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Maintaining independence and editorial freedom is essential to ...

The pharmaceutical company posted revenue of $16.66 billion in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $16.55 billion. Merck expects full-year earnings in ...

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...

BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the completion of the first milestone of ...

Pfizer hired Marra all the way back in 2002, at which time the new Havas Health exec had spent a few years working at Merck ...

Recurrent Energy said Liberty Solar, a 134 megawatt project in Liberty County, about 50 miles northeast of Houston, had ...

The planned launch of an in-house ad tech platform in 2025 signals ... (You can read the full research report on Netflix here >>>) Shares of Merck have gained +0.1% over the year-to-date period ...

The Gardasil franchise is the company's second largest sales driver behind Keytruda, and Merck remains steadfast it can garner more than $11 billion from the key product in 2030. Fewer than 10% of ...

International science and technology firm Merck has announced investment of over £4 million in its Life Science facility in Livingston, bringing new jobs to the town. Did you know with a Digital ...